Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 670 across all filing types
Latest filing 2024-11-26 Proxy Solicitation & In…
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Notice of the Postal Ballot
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice issued by Fermenta Biotech Limited pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It includes detailed information about the appointment and re-appointment of independent directors, the voting period, and instructions for remote e-voting. The document is a formal notice to shareholders to vote on specific resolutions via postal ballot, not the results of the vote or a report of the meeting. It is not an Annual Report, Management Report, or any financial statement. It is also not a Proxy Solicitation or Voting Results announcement. The document is a notice related to shareholder voting, specifically a Postal Ballot Notice, which fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) if it were results, but since this is the notice before voting, it is more aligned with Proxy Solicitation & Information Statement (PSI). However, the PSI category is for materials sent to shareholders to provide information and request votes for meetings, which matches the Postal Ballot Notice purpose. Therefore, the best classification is PSI.
2024-11-26 English
Intimation of investor meeting
Regulatory Filings Classification · 95% confidence The document is a short notice (1602 characters) informing about an upcoming investor meeting scheduled for December 2, 2024. It references that an Investor Presentation for July 2024 and Earnings Presentation for the quarter and half year ended September 30, 2024 have been uploaded on the company's and BSE's websites. The document explicitly states it is an intimation under SEBI regulations and does not contain the presentations themselves or detailed financial data. It serves as an announcement of the meeting and availability of presentations rather than the presentations or earnings release themselves. According to the 'Menu vs Meal' rule, such a short notice announcing the availability of reports is classified as a Regulatory Filing (RNS).
2024-11-26 English
Earnings presentation for quarter and half year ended September 30, 2024.
Earnings Release Classification · 95% confidence The document is titled 'Earnings Presentation for Quarter 2 of Financial Year 2024-25' and contains detailed financial data including standalone and consolidated revenue, EBITDA margins, net profit, EPS, and operational highlights for Q2 and H1 of FY25. It includes quarterly and half-yearly financial performance tables, historical income statements, and balance sheets. The document is approximately 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content focuses on financial results and operational highlights for a specific quarter and half-year period, which aligns with the characteristics of an Earnings Release or Earnings Presentation. Given the detailed financial data and the explicit mention of 'Earnings Presentation' in the document, the most appropriate classification is Earnings Release (ER).
2024-11-18 English
Newspaper advertisement of unaudited financials for quarter and half year ended September 30, 2024
Regulatory Filings
2024-11-15 English
Appointment and re-appointment of Independent Directors
Board/Management Information Classification · 95% confidence The document is a formal communication from the company to the stock exchange regarding the outcome of a Board Meeting held on November 14, 2024. It announces the appointment of a new Independent Director and the re-appointment of an existing Independent Director, including their terms and brief profiles. The document references compliance with SEBI regulations and mentions a postal ballot for shareholder approval. There are no financial statements or detailed financial performance data present. The content focuses on changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 6368 characters, which is sufficient for a detailed announcement but does not constitute a full report like an Annual Report or Interim Report. Therefore, the appropriate classification is MANG with high confidence.
2024-11-14 English
Unaudited financial results for quarter and half year ended September 30, 2024
Regulatory Filings
2024-11-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.